Prenatal diagnosis
Audio Summaries

Fetal Brain Abnormalities Following Laser Surgery for Twin-to-Twin Transfusion Syndrome: Imaging Patterns and Evolution

Jun 23, 2026

This study aimed to characterize the progression of severe brain injury in fetuses following fetoscopic laser ablation (FLA) for twin-to-twin transfusion syndrome (TTTS). The authors found that early imaging revealed acute hemorrhagic and ischemic changes, while late imaging showed irreversible destructive brain alterations, indicating a consistent pattern of injury that requires further investigation.

Determining Ethnic Disparities Inherent to Tier 3 Vs. Tier 4 Carrier Screening

Jun 22, 2026

The authors aimed to evaluate ethnic disparities in carrier status ascertainment between Tier 3 and Tier 4 carrier screening panels and to assess the effectiveness of Tier 4-only screening in a diverse population. Their findings indicate that Tier 4 panels significantly improve carrier detection across various ethnic groups, with a high prevalence of Tier 4-only variants and lower numbers needed to screen compared to Tier 3 panels. This supports the recommendation for universal Tier 4 carrier screening to better serve underrepresented populations.

Enhancing Prenatal Genetic Evaluation Through the Combination of Single-Gene Non-Invasive Prenatal Screening and Prenatal Imaging

Jun 22, 2026

This review explores how combining single-gene non-invasive prenatal screening (cfDNA-SGD) with prenatal imaging techniques can enhance genetic evaluation during pregnancy. The authors aim to assess the effectiveness of a specific cfDNA-SGD panel that screens for 25 conditions, while also emphasizing the importance of imaging modalities like ultrasound and fetal MRI in refining prenatal diagnoses and guiding clinical management. They highlight the need for confirmatory testing before making clinical decisions based on cfDNA-SGD results.

First-Trimester Molecular Screening for Fetal and Neonatal Alloimmune Thrombocytopenia: Early Identification of At-Risk Pregnancies

Jun 21, 2026

The authors aimed to evaluate the feasibility and clinical value of first-trimester molecular HPA screening to identify pregnancies at risk for fetal and neonatal alloimmune thrombocytopenia (FNAIT). Their study found that early screening successfully identified at-risk pregnancies, allowing for timely clinical interventions and management, including platelet transfusions for affected neonates. These results suggest that targeted prenatal screening programs could enhance the recognition and management of FNAIT, even in populations with low prevalence of certain maternal genotypes.

Is There Potential Clinical Utility in Reporting Variants of Uncertain Significance From Prenatal Sequencing?

Jun 19, 2026

The authors investigate the clinical utility of reporting variants of uncertain significance (VUS) identified through prenatal sequencing, particularly in the context of multidisciplinary team discussions. They found that VUS were reported in 41 out of 881 cases, with follow-up data indicating that over 50% of VUS were resolved through additional information, suggesting that reporting these variants can provide valuable insights for clinical decision-making despite initial uncertainties for parents.

Twin Anemia Polycythemia Sequence: Pretreatment Characteristics and Outcomes Stratified by Management Approach

Jun 18, 2026

The authors aimed to compare the characteristics and outcomes of Twin Anemia Polycythemia Sequence (TAPS) cases based on different treatment modalities, including expectant management, intrauterine transfusion, fetoscopic laser surgery, and selective fetal reduction. They found significant differences in gestational age at diagnosis, treatment to delivery intervals, and perinatal survival rates across the management approaches, while noting that placentation and TAPS etiology were less influential in treatment decisions. Overall, outcomes were favorable and did not significantly differ among the various management strategies.

Reference Ranges of Maximum Diameter and Volume of the Fetal Large Intestine During the Second-to Third-Trimester: An MRI Study

Jun 14, 2026

The authors aimed to establish normal reference ranges for the maximum diameter and volume of the fetal large intestine during the second and third trimesters, and to analyze their correlations with gestational age (GA). Through a retrospective analysis of MRI data from 387 fetuses, they found that both measurements increased with advancing GA and abdominal circumference, leading to the development of gestational week-specific percentile reference ranges and regression equations. These findings may aid in distinguishing between normal and abnormal intestinal development in fetuses.

Placental Dysfunction and Congenital Heart Disease: Investigating the Placenta-Heart Axis

Jun 11, 2026

The authors aimed to investigate the relationship between placental vascular pathology and the occurrence of congenital heart disease (CHD) in infants. Their findings indicate that maternal vascular malperfusion (MVM) is significantly more prevalent in infants with CHD compared to unaffected infants, suggesting a potential link between placental dysfunction and the development of CHD. Additionally, the study highlights that fetal vascular malperfusion (FVM) is associated with reduced fetal cerebral oxygenation and increased maternal age.

Sickle Cell Disease: Historical Overview and Current Therapies

Jun 11, 2026

The authors explore the historical context and current treatment options for sickle cell disease (SCD), emphasizing the limitations and risks associated with existing therapies, particularly hematopoietic stem cell transplantation. They highlight the urgent need for novel treatments that can cure SCD with a single intervention, specifically proposing in utero transplantation as a potential solution to prevent disease onset and its associated complications in affected infants.

Impact of Prenatal Cell-Free DNA Screening on Sex Chromosome Aneuploidy Diagnoses in Infants and Children

Jun 2, 2026

The authors aimed to evaluate the impact of prenatal cell-free DNA (cfDNA) screening on the diagnostic rates of sex chromosome aneuploidy (SCA) in infants and children. Their analysis revealed that the introduction of cfDNA screening was associated with a significant increase in SCA diagnoses among infants, while no notable change was observed in children, indicating that cfDNA screening may facilitate earlier detection of SCAs in younger populations.